Filtered By:
Condition: Hemorrhagic Stroke
Procedure: Craniotomy
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 276 results found since Jan 2013.
Hemorrhagic Stroke: Endoscopic Aspiration
Adv Tech Stand Neurosurg. 2022;44:97-119. doi: 10.1007/978-3-030-87649-4_5.ABSTRACTIntracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) carry a very dismal prognosis. Several medical and surgical attempts have been made to reduce mortality and to improve neurological outcomes in survivors. Aggressive surgical treatment of ICH through craniotomy and microsurgical evacuation did not prove to be beneficial to these patients, compared to the best medical treatment. Similarly, the conventional treatment of IVH using an EVD is often effective in controlling ICP only initially, as it is very likely for the EVD to ...
Source: Advances and Technical Standards in Neurosurgery - February 2, 2022 Category: Neurosurgery Authors: Alberto Feletti Alessandro Fiorindi Source Type: research
A Comparison of Outcomes Using Combined Intra- and Extradural versus Extradural-Only Repair of Tegmen Defects
Conclusion The results of this study suggest no difference in clinical outcomes between combined intra-/extradural versus extradural-only repair of tegmen defects. A simplified extradural-only repair strategy can be effective, and may reduce the morbidity of intradural reconstruction (seizures, stroke, and intraparenchymal hemorrhage). [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Journal of Neurological Surgery Part B: Skull Base - February 1, 2022 Category: Neurosurgery Authors: Khanna, Omaditya D'Souza, Glen Hattar-Medina, Ellina Karsy, Michael Chiffer, Rebecca C. Willcox, Thomas O. Farrell, Christopher J. Evans, James J. Tags: Original Article Source Type: research
Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma
In this study, we treated ten patients with newly diagnosed MG with apixaban, 2.5 mg twice daily beginning 2–21 days after craniotomy and continuing for up to 6 months. Unacceptable toxicity was defined by ≥ grade 2 CNS or non-CNS hemorrhage, a thromboembolic event (i.e. stroke) or cardiovascular event requiring anticoagulation or anti-platelet therapy. There were no unacc eptable toxicities to report and no treatment-related adverse events. None of the patients on the study were diagnosed with a VTE while receiving apixaban. We conclude that apixaban can be given safely to patients with primary MG shortly after cra...
Source: Journal of Thrombosis and Thrombolysis - August 4, 2021 Category: Hematology Source Type: research
Significance of endoscopic hematoma evacuation in elderly patients with spontaneous putaminal hemorrhage
CONCLUSION: The evacuation of deep-seated intracranial hematomas using the endoscope might improve functional outcomes and mortality, regardless of age.PMID:33880226 | PMC:PMC8053465 | DOI:10.25259/SNI_872_2020
Source: Surgical Neurology International - April 21, 2021 Category: Neurosurgery Authors: Naohide Fujita Hideaki Ueno Mitsuya Watanabe Yasuaki Nakao Takuji Yamamoto Source Type: research
